More than 5,000 applications received to participate in the NEUBIAS project coordinated by IRB Barcelona Blog Post

More than 5,000 people have applied to participate in the different training courses offered by the NEUBIAS project, which seeks to expand knowledge in the field of bioimage analysis. Coordinated by IRB Barcelona at PCB, ​​NEUBIAS is the only network of bio-imaging analysts in Europe. It has more than 250 members from 42 countries who share knowledge to improve image analysis technology.


Baula donates 18,000 cleaning kits to Càritas Girona Blog Post

The startup Baula, based in the Barcelona Science Park, has donated 18,000 kits of ecological cleaning products to Cáritas Diocesana de Girona, which will be distributed as basic necessities to vulnerable families cared for by the entity. The capsule format facilitates transportation and logistics compared to conventional products. The provision of goods to 18,000 families would equate to 72,000 kilograms of conventional cleaning products. In comparison, Baula’s tablets weigh a total of 4,500 kilograms.


Bioengineering contributes to new advances against childhood cancer Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park, the INCLIVA Health Research Institute and the Hospital Clínico de Valencia have discovered how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. The study, published in Scientific Reports, opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments.


Histones and their modifications are crucial for adaptation to cell stress Blog Post

The Cell Signaling laboratory at IRB Barcelona, ​​led by Eulàlia de Nadal and Francesc Posas at the Barcelona Science Park, has identified more than 200 regions (amino acids) in histones that are responsible for regulating the response to cell stress. The study reports that histones undergo distinct modifications depending on the type of cell stress.


Juan Carlos Kaski, new Chief Medical Officer of GlyCardial Diagnostics Blog Post

GlyCardial Diagnostics, based in the Barcelona Science Park, announces the appointment of Prof. Juan Carlos Kaski as Chief Medical Officer. The company –a spinoff of the Research Institute of the Hospital de la Santa Creu i Sant Pau (IR-HSCSP) and the Spanish National Research Council (CSIC), is conducting a clinical trial to validate the performance of Apo J-Glyc as a novel biomarker for the early detection of Myocardial Ischaemia.


AECC backs cancer research involving 3D models at IRB Barcelona Blog Post

The Asociación Española Contra el Cáncer (AECC) –in collaboration with Cancer Research UK (CRUK) and the Fondazione AIRC per la Ricerca sul Cancro (AIRC)– has awarded more than €500,000 euros of funding to an IRB Barcelona project, within the framework of the Accelerator Awards call.  the project will allow researchers to study the complexity and heterogeneity of cancer using culturable mini-cancers, also known as organoids, derived from patients.